XBI

3 High Demand ETFs: Can You Explain The Investor Confidence?

Jobless claims have been rising, earnings, and revenue growth stalling. Are there any reasons for market optimism? Take a close look at these 3 charts. More 

3 ETF Trends That Might Shock The “Risk-On” Mindset

Stocks are not the only asset in demand, and investors looking for further proof need to see these 3 ETF charts for strategic opportunities More 

XBI – Be Careful With This Biotech ETF After Its Violent Breakout

After last week's breakout and rally, the SPDR S&P Biotech ETF (XBI) is well overbought. Traders must closely watch Intercept Pharmaceuticals (ICPT). More 

3 Attractive Low P/E ETFs For Investors to Consider Today

Many of the same biases towards U.S. ETFs are in place, despite the availability of underappreciated foreign stock ETFs available, including these...Read More. More 

The 3 Best Sectors to Buy for 2014

Here are three sectors to watch in the new year that may attract the most cash and boast the best stocks to buy in 2014. More 

Bull’s Eye Report: Gilead Sciences (GILD)

Despite its recent runup, Gilead Sciences (GILD) shows room for immediate upside. More 

How to Profit From Every Biotech Buyout

Amgen's acquisition of Onyx underscores the fact that one simple biotech investment may also be the best one. More